The American Cancer Society National Lung Cancer Roundtable strategic plan: Provider engagement and outreach

The American Cancer Society National Lung Cancer Roundtable strategic plan for provider engagement and outreach addresses barriers to the uptake of lung cancer screening, including lack of provider awareness and guideline knowledge about screening, concerns about potential harms from false-positive examinations, lack of time to implement workflows within busy primary care practices, insufficient infrastructure and administrative support to manage a screening program and patient follow-up, and implicit bias based on sex, race/ethnicity, social class, and smoking status. Strategies to facilitate screening include educational programming, clinical reminder systems within the electronic medical record, decision support aids, and tools to track nodules that can be implemented across a diversity of practices and health care organizational structures. PLAIN LANGUAGE SUMMARY: The American Cancer Society National Lung Cancer Roundtable strategic plan to reduce deaths from lung cancer includes strategies designed to support health care professionals, to better understand lung cancer screening, and to support adults who are eligible for lung cancer screening by providing counseling, referral, and follow-up.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2024-09-20
DOI
https://doi.org/10.1002/cncr.34555
Citations
8
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The American Cancer Society National Lung Cancer Roundtable strategic plan: Provider engagement and outreach

Robert Allen Smith, Jan M. Eberth, Jennifer A. Lewis, Deborah E. Klein et al.
8 citations
Cancer
Lung Cancer Diagnosis and Treatment
2.09
article

The American Cancer Society National Lung Cancer Roundtable strategic plan: Provider engagement and outreach

Robert Allen Smith, Jan M. Eberth, Jennifer A. Lewis, Deborah E. Klein, Lisa Carter‐Harris, Jamie L. Studts, Betty C. Tong, Thomas P. Houston, Ella A. Kazerooni
article en
8 citations

Abstract

The American Cancer Society National Lung Cancer Roundtable strategic plan for provider engagement and outreach addresses barriers to the uptake of lung cancer screening, including lack of provider awareness and guideline knowledge about screening, concerns about potential harms from false-positive examinations, lack of time to implement workflows within busy primary care practices, insufficient infrastructure and administrative support to manage a screening program and patient follow-up, and implicit bias based on sex, race/ethnicity, social class, and smoking status. Strategies to facilitate screening include educational programming, clinical reminder systems within the electronic medical record, decision support aids, and tools to track nodules that can be implemented across a diversity of practices and health care organizational structures. PLAIN LANGUAGE SUMMARY: The American Cancer Society National Lung Cancer Roundtable strategic plan to reduce deaths from lung cancer includes strategies designed to support health care professionals, to better understand lung cancer screening, and to support adults who are eligible for lung cancer screening by providing counseling, referral, and follow-up.

CancerVol. 130(23)
American Cancer Society (US), Memorial Sloan Kettering Cancer Center (US), Vanderbilt University (US), University of Michigan (US), Swedish Medical Center (US), VA Tennessee Valley Healthcare System (US), Geriatric Research Education and Clinical Center (US), Duke Medical Center (US), Vanderbilt-Ingram Cancer Center, The Ohio State University (US), Drexel University (US), Vanderbilt University Medical Center (US), University of Colorado Denver (US)
U.S. Department of Veterans Affairs, Amgen, Bristol-Myers Squibb, AstraZeneca, Sanofi, Gilead Sciences, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Regeneron Pharmaceuticals, Novocure, Georgia Clinical and Translational Science Alliance, Daiichi-Sankyo, National Institutes of Health, Genentech, Foundation Medicine, National Heart, Lung, and Blood Institute, National Cancer Institute, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 12%
Lung Cancer Diagnosis and Treatment
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.